相似文献
1
Treatment of stiff person syndrome with rituximab.
J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):999-1001. doi: 10.1136/jnnp.2004.051144.
2
Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy.
Intern Med. 2010;49(3):237-41. doi: 10.2169/internalmedicine.49.2821. Epub 2010 Feb 1.
3
Teaching NeuroImages: Severe spasms resembling status dystonicus as an unusual presentation of stiff-person syndrome.
Neurology. 2019 Feb 12;92(7):e748. doi: 10.1212/WNL.0000000000006925.
4
Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.
J Clin Rheumatol. 2010 Aug;16(5):237-9. doi: 10.1097/RHU.0b013e3181e931fa.
5
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
PLoS One. 2010 May 26;5(5):e10838. doi: 10.1371/journal.pone.0010838.
6
Stiff-person Syndrome with Waldenström Macroglobulinemia.
Intern Med. 2018 Nov 15;57(22):3313-3316. doi: 10.2169/internalmedicine.1043-18. Epub 2018 Jul 6.
7
Successful treatment of stiff person syndrome with sequential use of tacrolimus.
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1177-80. doi: 10.1136/jnnp-2013-305425. Epub 2013 May 28.
8
[Successful treatment with rituximab in a refractory Stiff-person syndrome].
Rev Neurol (Paris). 2012 Apr;168(4):375-8. doi: 10.1016/j.neurol.2011.09.008. Epub 2012 Feb 14.
9
Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies.
Am J Ophthalmol. 2005 Jul;140(1):142-4. doi: 10.1016/j.ajo.2004.12.052.
10
Rituximab treatment of stiff-person syndrome in a patient with thymoma, diabetes mellitus and autoimmune thyroiditis.
J Clin Neurosci. 2010 Mar;17(3):389-91. doi: 10.1016/j.jocn.2009.06.015. Epub 2010 Jan 13.
引用本文的文献
1
Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review.
J Neurol. 2025 May 24;272(6):417. doi: 10.1007/s00415-025-13157-2.
2
Recent advances in autoimmune encephalitis.
Arq Neuropsiquiatr. 2024 Dec;82(12):1-13. doi: 10.1055/s-0044-1793933. Epub 2024 Dec 20.
3
Expanding the Understanding of Stiff-Person Syndrome: Insights from 17 Cases in India.
Ann Indian Acad Neurol. 2024 Jul 1;27(4):419-425. doi: 10.4103/aian.aian_92_24. Epub 2024 Aug 16.
4
An update on malignant tumor-related stiff person syndrome spectrum disorders: clinical mechanism, treatment, and outcomes.
Front Neurol. 2023 Oct 4;14:1209302. doi: 10.3389/fneur.2023.1209302. eCollection 2023.
5
Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.
Neurol Neuroimmunol Neuroinflamm. 2023 Apr 14;10(3). doi: 10.1212/NXI.0000000000200109. Print 2023 May.
6
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update.
Bioengineering (Basel). 2023 Jan 29;10(2):176. doi: 10.3390/bioengineering10020176.
7
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody-Positive Stiff-Person Syndrome.
Neurol Neuroimmunol Neuroinflamm. 2022 Jul 7;9(5). doi: 10.1212/NXI.0000000000200011. Print 2022 Sep.
8
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.
Neurotherapeutics. 2022 Apr;19(3):832-847. doi: 10.1007/s13311-022-01188-w. Epub 2022 Jan 27.
9
Anti-amphiphysin positive stiff-person syndrome due to invasive ductal carcinoma in a male patient.
BMJ Case Rep. 2021 May 24;14(5):e237738. doi: 10.1136/bcr-2020-237738.
10
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.
Ther Adv Neurol Disord. 2021 Mar 30;14:17562864211003486. doi: 10.1177/17562864211003486. eCollection 2021.
Zotero 插件